
Amyris Biotechnologies
Inventure Chemicals develops an ethanol and biodiesel conversion process by using a variety of raw materials including algae.
Our primary mission is helping agri-business, oleo-chemical and biofuel companies find ways to turn waste products and by-products into value-added materials to increase overall profitability, and have pioneered many processes toward these ends.
| Headquarter | P.O. Box 530 Gig Harbor, WA United States of America |
|---|---|
| Website | www.inventurechem.com |
| Founding Date | 2007 |
| Tel | 205-764-1963 |
| Company Status | Private |
Inventure Chemicals competitors include Amyris Biotechnologies. Inventure Chemicals ranks 2nd in Overall Culture Score on Comparably vs its competitors. See below how Inventure Chemicals compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.
2 employees at Inventure Chemicals have reviewed Inventure Chemicals across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was months ago.

The prevailing opinion from Comparably users in Seattle about their company is that it was very prepared on their first day. Seattle employees concluded that their overall onboarding experience was positive. 70% said their direct manager was helpful with their acclimation during the first 90 days. First impressions are important, and how prepared a company is on your first day leaves a lasting impression.
At this moment no Inventure Chemicals employees have provided insight into whether or not they clearly understand Inventure Chemicals' KPIs and OKRs.

No Recent Jobs found for Inventure Chemicals on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

What is Inventure Chemicals address?
Inventure Chemicals location is at P.O. Box 530
Who are Inventure Chemicals competitors?
Inventure Chemicals main competitors are Amyris Biotechnologies